ArticleJournal of the National Cancer Institute2023
Design of phase II oncology trials evaluating combinations of experimental agents.
Elad Sharon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it